Literature DB >> 24189740

New antitumoral cyclopeptides.

E Bernardi1, J L Fauchère, G Atassi, P Viallefont, R Lazaro.   

Abstract

Chlamydocin is a powerfulin vitro antitumoral agent, quickly inactivatedin vivo. A series of cyclic tetrapeptides related to chlamydocin or HC toxin and bearing a bioactive alkylating group on anε-amino-lysyl function have been examined for their antitumoral activity on L1210 and P388 murine leukemia cell lines. One analog was found to be potent at inhibiting L1210 cell proliferation and had a higher therapeutic index than the reference compound bis-β-chloroethylnitrosourea on thein vivo P388-induced leukemia model.

Entities:  

Year:  1994        PMID: 24189740     DOI: 10.1007/BF00813752

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  4 in total

1.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

2.  [Isolation and structural clarification of chlamydocin].

Authors:  A Closse; R Huguenin
Journal:  Helv Chim Acta       Date:  1974-04-27       Impact factor: 2.164

3.  Reciprocal biological activities of the cyclic tetrapeptides chlamydocin and HC-toxin.

Authors:  J D Walton; E D Earle; H Stähelin; A Grieder; A Hirota; A Suzuki
Journal:  Experientia       Date:  1985-03-15

4.  Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide.

Authors:  H Stähelin; A Trippmacher
Journal:  Eur J Cancer       Date:  1974-12       Impact factor: 9.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.